Viewing Study NCT06276504


Ignite Creation Date: 2025-12-24 @ 9:16 PM
Ignite Modification Date: 2025-12-30 @ 11:16 AM
Study NCT ID: NCT06276504
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-02-26
First Post: 2024-02-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab in Progressive Multifocal Leukoencephalopathy (PML) in Immunocompromised Patients Without HIV Infection
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module